Composition containing 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil
US4481203A · kind A · utility
4Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1980 |
| Grant date | Nov 6, 1984 |
| Priority date | — |
| Expiry date | Dec 3, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for delivering 5-fluorouracil to cancer tissues, of a cancer sensitive to 5-fluorouracil, in warm blooded animals, comprising effective amounts of 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil in a molar ratio of 1:0.1-10, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.